Wednesday, June 10, 2026

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

Jang Dong-hyuk’s U.S. Meetings: Uncovering the Secrets Behind Korea-U.S. Alliance Discussions

Jang Dong-hyuk of the People Power Party discusses U.S. relations and intelligence leaks in a meeting with Deputy Ambassador Heller.

Lunit Scope: How AI Biomarkers Are Revolutionizing Cancer Treatment at AACR 2026

Lunit to present six AI biomarker studies at AACR 2026, showcasing advancements in cancer treatment and AI technology.

HS Hyosung Investment Reaches Key Milestone in Bio-Based Acrylonitrile Development

EconomyHS Hyosung Investment Reaches Key Milestone in Bio-Based Acrylonitrile Development
The Hyosung Group headquarters in Gongdeok-dong, Mapo-gu, Seoul 2024.6.14 / News1
The Hyosung Group headquarters in Gongdeok-dong, Mapo-gu, Seoul 2024.6.14 / News1

HS Hyosung Advanced Materials announced on Wednesday that its investment in the American chemical technology startup Trillium Renewable Chemicals has reached a significant milestone. The production technology for acrylonitrile has entered the demonstration phase.

Acrylonitrile is a crucial raw material widely used in everyday products such as high-performance plastics, synthetic rubber, and fibers. It’s also a key component in HS Hyosung’s carbon fiber production.

HS Hyosung Advanced Materials made history in 2011 by becoming the first Korean company to independently develop carbon fiber. In 2013, they ramped up production by launching a commercial plant with an annual capacity of 2,000 tons.

Often hailed as a dream material, carbon fiber is composed of carbon elements. It’s remarkably lightweight – just a quarter of steel’s weight – yet boasts ten times the strength and seven times the elasticity.

Building on its established industrial materials business, HS Hyosung Advanced Materials is now focusing on developing high-value materials, with carbon fiber at the forefront.

The company took a leading role in Trillium’s 13 million USD Series B funding round, backing the demonstration project. Belgian venture capital firm Capricorn Partners also joined as a co-investor.

Trillium’s innovative approach involves producing acrylonitrile from glycerol, a byproduct of biodiesel production. This strategy aims to offer sustainable alternatives to traditional petrochemical-based products.

In February, Trillium achieved a world first by completing construction of Project Falcon, a demonstration plant for glycerol-based bio-acrylonitrile.

Project Falcon is set to begin full-scale commissioning in the second quarter of 2026, with product shipments expected to start later this year.

The newly secured funds will support demonstration plant operations, ongoing technological innovation, and detailed design work for the first commercial-scale plant.

Lee Young-jun, Executive Director of HS Hyosung Advanced Materials, commented on the milestone: With Project Falcon’s completion, they’re on the cusp of commercializing Trillium’s bio-acrylonitrile. This marks a significant step in the sustainable management efforts, proving it can seamlessly integrate bio-based raw materials into existing processes and achieve commercial-scale production.

Check Out Our Content

Check Out Other Tags:

Most Popular Articles